Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Larson

Showing results (121-130 of 300) with videos related to

Pageof 30
Sort By:
The Annals of Thoracic Surgery|February 9, 2002
An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancerTim Akhurst, Robert J Downey, Michelle S Ginsberg, et al.
Pediatric Blood & Cancer|March 10, 2010
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastomaSonal Bhandari, Nai-Kong V Cheung, Brian H Kushner, et al.
Urology|May 29, 2002
Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancerMichael J Morris, Timothy Akhurst, Iman Osman, et al.
Nuclear Medicine Communications|December 5, 2013
How to assess background activity: introducing a histogram-based analysis as a first step for accurate one-step PET quantificationIrene A Burger, Hebert A Vargas, Brad J Beattie, et al.
American Journal of Clinical Oncology|October 8, 2008
Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancerCarlo Greco, Sadek A Nehmeh, Heiko Schöder, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2005
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanningRichard J Robbins, Qiang Wan, Ravinder K Grewal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2010
(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivoMikhail Doubrovin, Tatiana Kochetkova, Elmer Santos, et al.
AJR. American Journal of Roentgenology|December 21, 2006
Combined CT colonography and 18F-FDG PET of colon polyps: potential technique for selective detection of cancer and precancerous lesionsMarc J Gollub, Tim Akhurst, Arnold J Markowitz, et al.
Molecular Imaging|January 26, 2013
Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanomaLars Stelter, Michael J Evans, Achim A Jungbluth, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2008
Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomasMichelle S Bradbury, Dolores Hambardzumyan, Pat B Zanzonico, et al.
Pageof 30

Showing results (121-130 of 300) with videos related to

Sort By:
Pageof 30
The Annals of Thoracic Surgery|February 9, 2002
An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancerTim Akhurst, Robert J Downey, Michelle S Ginsberg, et al.
Pediatric Blood & Cancer|March 10, 2010
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastomaSonal Bhandari, Nai-Kong V Cheung, Brian H Kushner, et al.
Urology|May 29, 2002
Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancerMichael J Morris, Timothy Akhurst, Iman Osman, et al.
Nuclear Medicine Communications|December 5, 2013
How to assess background activity: introducing a histogram-based analysis as a first step for accurate one-step PET quantificationIrene A Burger, Hebert A Vargas, Brad J Beattie, et al.
American Journal of Clinical Oncology|October 8, 2008
Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancerCarlo Greco, Sadek A Nehmeh, Heiko Schöder, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2005
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanningRichard J Robbins, Qiang Wan, Ravinder K Grewal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2010
(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivoMikhail Doubrovin, Tatiana Kochetkova, Elmer Santos, et al.
AJR. American Journal of Roentgenology|December 21, 2006
Combined CT colonography and 18F-FDG PET of colon polyps: potential technique for selective detection of cancer and precancerous lesionsMarc J Gollub, Tim Akhurst, Arnold J Markowitz, et al.
Molecular Imaging|January 26, 2013
Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanomaLars Stelter, Michael J Evans, Achim A Jungbluth, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2008
Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomasMichelle S Bradbury, Dolores Hambardzumyan, Pat B Zanzonico, et al.
Pageof 30